Form 4 for ENTX Entera Bio Ltd.
Accepted 2025-04-30 00:00:00 ET · period of report 2025-04-28 · accession 0001178913-25-001539 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-30 | 2025-04-28 | ENTX | Galitzer Hillel | COO | A - Grant | $0.00 | +26.3K | 90.6K | +41% | $0 |
| D | 2025-04-30 | 2025-04-28 | ENTX | Galitzer Hillel | COO | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value NIS 0.0000769 per share | 2025-04-28 | A | A | 26,316 | $0.00 | 90,573 | D | — | — | (F1) Represents a grant of stock-settled restricted stock units. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 28, 2025. |
| 2 | Derivative | Stock Option (right to buy) | 2025-04-28 | A | A | 100,000 | $0.00 | 100,000 | D | $2.28 · — to 2025-04-28 | 100,000 Ordinary Shares, par value NIS 0.0000769 per share | (F2) The options vest over a three-year period with 33% of the options vesting on April 28, 2025, the first anniversary of the vesting commencement date, and the remaining options vesting ratably on a quarterly basis over the remaining three-year period. |